20 insiders have filed at LIVN since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Kozy William A | Director | 32.6k | 0.058% | ||
| Moore Daniel Jeffrey | Director | 27.5k | 0.049% | 2 sells $3.4M | |
| Shvartsburg Alex | Chief Financial Officer | 26.7k | 0.048% | ||
| Hebbelinck Trui | Chief Human Resources Officer | 13.8k | 0.025% | ||
| Bolton Stephanie | President, Global Epilepsy | 12.8k | 0.023% | ||
| Enxing Seng Stacy | Director | 11.8k | 0.021% | ||
| O'Kane Sharon | Director | 11.3k | 0.02% | ||
| Saia Andrea Lynn | Director | 10.8k | 0.019% | ||
| Poletti Franco | President, Cardiopulmonary | 9.2k | 0.016% | ||
| Schermerhorn Todd C | Director | 9.1k | 0.016% | ||
| Bianchi Francesco | Director | 9.0k | 0.016% | 3 sells $218k | |
| Hutchinson Michael Damon | SVP, CLO And Company Secretary | 6.8k | 0.012% | ||
| Wilver Peter M | Director | 6.7k | 0.012% | ||
| Story Brooke | Director | 6.2k | 0.011% | 1 sells $13k | |
| Barry James Christopher | Director | 4.4k | <0.01% | ||
| Makatsaria Vladimir | Chief Executive Officer | 4.3k | <0.01% | ||
| Podlogar Susan M | Director | 2.1k | <0.01% | ||
| Tezel Ahmet | Chief Innovation Officer | 1.9k | <0.01% | ||
| Kozmina Natalia | Chief Human Resources Officer | ||||
| Zurbay Donald | Director |
Full register at boothcheck.com/insiders/LIVN. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.